View in EDS

Antagonism of the mammalian target of rapamycin selectively mediates metabolic effects of epidermal growth factor receptor inhibition and protects human malignant glioma cells from hypoxia-induced cell death.

Saved in:
Bibliographic Details
Title: Antagonism of the mammalian target of rapamycin selectively mediates metabolic effects of epidermal growth factor receptor inhibition and protects human malignant glioma cells from hypoxia-induced cell death.
Authors: Ronellenfitsch, Michael W.1, Brucker, Daniel P.2, Burger, Michael C.2, Wolking, Stefan1, Tritschler, Felix1, Rieger, Johannes2, Wick, Wolfgang3, Weller, Michael1,4, Steinbach, Joachim P.2, joachim.steinbach@med.uni-frankfurt.de
Source: Brain: A Journal of Neurology; Jun2009, Vol. 132 Issue 6, p1509-1522, 14p, 6 Graphs
Database: Applied Science & Technology Source
Description
ISSN:00068950
DOI:10.1093/brain/awp093